Abstract:Red blood cell (RBC) alloimmunization remains a major complication for transfusion-dependent patients such as those with sickle cell disease. Alloimmunization rates in transfusion recipients lacking the antigen can be as high as 70% for the RhD antigen or much lower for minor antigens. Several factors including the host's immune status have been shown to influence the recipient's ability to react to RBC alloantigens. However, it is not clear whether inherent differences in immune response can be identified between those who have or have not developed RBC alloantibodies following multiple transfusions. Increasing evidence indicates that CD4+ regulatory T cells (Tregs) characterized by co-expression of CD25 and the forkhead/winged helix transcription factor (Foxp3) are key regulators of a wide spectrum of immune responses. We have recently found that manipulation of Treg numbers affects the rate and the frequency of RBC alloimmunization in mouse models. We hypothesized that Treg number or function may be reduced in multi-transfused recipients who develop alloantibodies compared to those who do not. To test this, we established a transfusion regimen in which B6 mice were first injected with RBCs from mice transgenic for human glycophorin A (huGPA) antigen plus CpG dinucleotides as an inflammatory signal and thereafter on a weekly basis for three weeks with GPA RBCs alone. Using this protocol, about 50% of mice (n=23, three separate experiments) developed anti-huGPA alloantibodies (IgM and IgG) which were pathogenic based on red cell survival studies. No significant differences in the frequency of Foxp3+CD25+ splenic Treg population between mice that produced alloantibodies (n=12) versus those that did not (n=11) (9.6% ± 0.7% vs. 9.5% ± 0.7%, p=0.9) as measured by intracellular staining of CD4+ T cells was observed. In addition, sorted splenic CD4+CD25+ Tregs isolated from mice that had made allo-anti-huGPA and those that did not were equally anergic following stimulation (p≥0.2), a characteristic of normal Tregs whereas effector CD4+CD25− cells from both groups of mice were highly proliferative. In contrast, when co-cultured at different suppressor/effector ratios (1:4, 1:8 and 1:16), Tregs from transfused immunized mice had an overall twofold less ability in suppressing autologous CD4+CD25− than Tregs from transfused non-immunized mice (p<0.05, n=3 separate experiments). To distinguish whether the reduced Treg suppressive activity of mice that had made alloantibodies was due to impaired suppressor function of the Tregs or a result of increased resistance to suppression by the CD4+CD25− T cells, we compared the suppressive effects of Tregs of these two groups of mice on proliferation of autologous and allogeneic CD4+CD25− cells (n=3). We found that CD4+CD25+ Tregs from transfused non-immunized mice inhibited the proliferation of alloimmunized and non-alloimmunized CD4+CD25− effector cells to the same degree (suppression=27% at suppressor/effector ratio 1:8). In contrast, CD4+CD25+ Tregs from transfused alloimmunized mice were less effective suppressors of CD4+CD25− cells from either immunized or non-immunized mice (suppression=55% at suppressor/effector ratio 1:8). Altogether our data suggest differences in functional capacities of Tregs in multi-transfused mice which have developed alloantibodies versus those who have not. This may underlie the differences in immune response in transfused recipients which consequently dictate the outcome of the induction of red cell alloantibodies.

Effects of storage blood transfusion on balance of helper T cell 1 and 2 in melanoma bearing mice

Extracellular Ubiquitin is the Causal Link Between Stored Blood Transfusion Therapy and Tumor Progression in a Melanoma Mouse Model

Effect of storage period of red blood cell suspensions on helper T-cell subpopulations

[Effect of RBC Transfusion on T Lymphocyte Subsets of Patients with Hematologic Malignancies].

[Experimental Study of Tripterygium Hypoglaucum (level) Hutch on Preventing Acute Graft-Versus-host Disease in Bone Marrow Transplantation Mice].

The impact of blood Transfusion on T Helper Cells and Cytokines in Transfusion-Refractory Patients: a Prospective Study

Effects of blood transfusion on cellular immuno-function in patients with laryngeal carcinoma

Immunologic Changes to Autologous Transfusion after Operational Trauma in Malignant Tumor Patients: Neopterin and Interleukin-2

[Influence of Donor Treg Cells on GVHD and GVL Effects after Allogeneic Bone Marrow Transplantation in Mice].

Synergistic effects of IL-2 and IL-12 on antitumor activity of human PBMC in vitro

[Influence of Mouse Genetic Engineering Regulatory T Cells Infusion on Post-Allogeneic Bone Marrow Transplantation Acute Graft-Versus-host Disease in Mice].

Prestorage Leucofiltration of Red Blood Cell Suspensions Modulates Storage Time-Dependent Suppression of in vitro Cytokine Release

The effect of bone marrow-derived mesenchymal stem cell transplantation on B cell activating factor and B cell activation in MRL/Ipr mouse

Stored red blood cell transfusion induces regulatory T cells

MiR-33a-5p in stored red blood cells regulates genes of innate immune response and promotes inflammation

Transfusion-associated adverse reactions (TAARs) and cytokine accumulations in the stored blood components: the impact of prestorage versus poststorage leukoreduction

Effect of Allogeneic Blood Transfusion and Preoperative Autologous Blood Donation on Perioperative Immune Function in Patients with Gastrointestinal Tumor

Immunologic profiles of red blood cells using in vitro models of transfusion

Differences in Regulatory T Cell Function in Alloimmunized Versus Non-Alloimmunized Mice Following Multiple Red Cell Transfusions

Effects of bone marrow mesenchymal cells from immune thrombocytopenia patients on the biological behaviors of megakaryocytes

Influence of intraoperative blood transfusion on tumor growth in rats